283 related articles for article (PubMed ID: 15818102)
81. Controlled trial of medical therapy for active upper gastrointestinal bleeding and prevention of rebleeding.
Zuckerman G; Welch R; Douglas A; Troxell R; Cohen S; Lorber S; Melnyk C; Bliss C; Christiansen P; Kern F
Am J Med; 1984 Mar; 76(3):361-6. PubMed ID: 6367452
[TBL] [Abstract][Full Text] [Related]
82. Comparison of the efficacy and safety between generic intravenous omeprazole (Zefxon) and original omeprazole (Losec) in the adjunct treatment of non-variceal upper gastrointestinal bleeding in Siriraj Hospital.
Lohsiriwat D; Saejong R; Lohsiriwat V; Tongsai S; Thamlikitkul V
J Med Assoc Thai; 2011 Nov; 94(11):1357-64. PubMed ID: 22256476
[TBL] [Abstract][Full Text] [Related]
83. Intravenous omeprazole prevents rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized controlled study.
Chua RT; Lin HJ; Wang K; Perng CL; Lo WC; Lee CH; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Feb; 57(2):139-45. PubMed ID: 8634929
[TBL] [Abstract][Full Text] [Related]
84. Effect of acidified enteral feedings on gastric colonization in the critically ill patient.
Heyland D; Bradley C; Mandell LA
Crit Care Med; 1992 Oct; 20(10):1388-94. PubMed ID: 1395658
[TBL] [Abstract][Full Text] [Related]
85. Effects of oral/enteral nutrition alone versus plus pantoprazole on gastrointestinal bleeding in critically ill patients with low risk factor: a multicenter, randomized controlled trial.
Gündoğan K; Karakoc E; Teke T; Zerman A; Esmaoglu A; Temel Ş; Güven M; Sungur M
Turk J Med Sci; 2020 Jun; 50(4):776-783. PubMed ID: 32151119
[TBL] [Abstract][Full Text] [Related]
86. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
Labenz J; Peitz U; Leusing C; Tillenburg B; Blum AL; Börsch G
Gut; 1997 Jan; 40(1):36-41. PubMed ID: 9155573
[TBL] [Abstract][Full Text] [Related]
87. Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment.
Savarino V; Mela GS; Zentilin P; Cutela P; Mansi C; Vassallo A; Franceschi M; Mela MR; Dallorto E; Celle G
Am J Gastroenterol; 1993 Jul; 88(7):1088-92. PubMed ID: 8317411
[TBL] [Abstract][Full Text] [Related]
88. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial.
Pateron D; Vicaut E; Debuc E; Sahraoui K; Carbonell N; Bobbia X; Thabut D; Adnet F; Nahon P; Amathieu R; Aout M; Javaud N; Ray P; Trinchet JC;
Ann Emerg Med; 2011 Jun; 57(6):582-9. PubMed ID: 21333385
[TBL] [Abstract][Full Text] [Related]
89. Pharmacokinetic and pharmacodynamic effects of two omeprazole formulations on stomach pH and gastric ulcer scores.
Raidal SL; Andrews FM; Nielsen SG; Trope G
Equine Vet J; 2017 Nov; 49(6):802-809. PubMed ID: 28432741
[TBL] [Abstract][Full Text] [Related]
90. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
Osteyee JL; Banner W
Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
[TBL] [Abstract][Full Text] [Related]
91. Omeprazole versus ranitidine in the medical treatment of acute upper gastrointestinal bleeding: assessment by early repeat endoscopy.
Fasseas P; Leybishkis B; Rocca G
Int J Clin Pract; 2001 Dec; 55(10):661-4. PubMed ID: 11777288
[TBL] [Abstract][Full Text] [Related]
92. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study.
Baghaie AA; Mojtahedzadeh M; Levine RL; Fromm RE; Guntupalli KK; Opekun AR
Crit Care Med; 1995 Apr; 23(4):687-91. PubMed ID: 7712759
[TBL] [Abstract][Full Text] [Related]
93. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
Lugo RA; Harrison AM; Cash J; Sweeley J; Vernon DD
Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
[TBL] [Abstract][Full Text] [Related]
94. Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related upper gastrointestinal bleeding: a prospective, multicenter, double-blind, randomized trial. The Ranitidine Head Injury Study Group.
Metz CA; Livingston DH; Smith JS; Larson GM; Wilson TH
Crit Care Med; 1993 Dec; 21(12):1844-9. PubMed ID: 8252888
[TBL] [Abstract][Full Text] [Related]
95. Omeprazole pharmacodynamics and gastric acid suppression in critically ill pediatric transplant patients.
Olsen KM; Bergman KL; Kaufman SS; Rebuck JA; Collier DS
Pediatr Crit Care Med; 2001 Jul; 2(3):232-7. PubMed ID: 12793947
[TBL] [Abstract][Full Text] [Related]
96. The value of early enteral nutrition in the prophylaxis of stress ulceration in the severely burned patient.
Raff T; Germann G; Hartmann B
Burns; 1997 Jun; 23(4):313-8. PubMed ID: 9248640
[TBL] [Abstract][Full Text] [Related]
97. Continuous infusions of nizatidine are safe and effective in the treatment of intensive care unit patients at risk for stress gastritis. The Nizatidine Intensive Care Unit Study Group.
Cloud ML; Offen W
Scand J Gastroenterol Suppl; 1994; 206():29-34. PubMed ID: 7863249
[TBL] [Abstract][Full Text] [Related]
98. The effects on intragastric acidity of per-gastrostomy administration of an alkaline suspension of omeprazole.
Sharma VK; Vasudeva R; Howden CW
Aliment Pharmacol Ther; 1999 Aug; 13(8):1091-5. PubMed ID: 10468686
[TBL] [Abstract][Full Text] [Related]
99. Comparison of the antisecretory effects of omeprazole when administered intravenously, as acid-stable granules and as an oral paste in horses.
Haven ML; Dave K; Burrow JA; Merritt AM; Harris D; Zhang D; Hickey GJ
Equine Vet J Suppl; 1999 Apr; (29):54-8. PubMed ID: 10696295
[TBL] [Abstract][Full Text] [Related]
100. Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery.
Hata M; Shiono M; Sekino H; Furukawa H; Sezai A; Iida M; Yoshitake I; Hattori T; Wakui S; Soeda M; Taoka M; Negishi N; Sezai Y
Circ J; 2005 Mar; 69(3):331-4. PubMed ID: 15731540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
